image
Nurix Therapeutics, Inc. NRIX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 22.92
-14.7 %
$ 1.62 B
Market Cap
-7.99
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-11-30 99.31% 13.31% 15.67%
Annual Report FY 10-K 2022-11-30 29.84% -41.68% -55.97%
Annual Report FY 10-K 2021-11-30 66.95% -171.02% -81.41%
Annual Report FY 10-K 2020-11-30 -42.73% -99.28% -192.24%
Annual Report FY 10-K 2019-11-30 -16.91% -130.15% -128.32%
Annual Report FY 10-K 2018-11-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-08-31 -31.84% -32.38% -36.49%
Quarterly Report Q2 8-K 2024-05-31 -60.58% -104.44% -81.36%
Quarterly Report Q1 8-K 2024-02-29 30.74% -17.50% -5.28%
Quarterly Report Q4 8-K 2023-11-30 123.49% -0.60% 6.89%
Quarterly Report Q3 8-K 2023-08-31 71.13% 17.27% 14.35%
Quarterly Report Q2 8-K 2023-05-31 168.33% 51.67% 41.45%
Quarterly Report Q1 8-K 2023-02-28 31.85% 16.51% -1.49%
Quarterly Report Q4 8-K 2022-11-30 -8.29% -10.62% -28.29%
Quarterly Report Q3 8-K 2022-08-31 5.26% -55.02% -61.11%
Quarterly Report Q2 8-K 2022-05-31 61.22% -70.90% -73.07%
Quarterly Report Q1 8-K 2022-02-28 92.00% -74.34% -72.59%
Quarterly Report Q4 8-K 2021-11-30 10.57% -89.32% -89.69%
Quarterly Report Q3 8-K 2021-08-31 150.97% -55.72% -51.09%
Quarterly Report Q2 8-K 2021-05-31 69.56% -348.05% -99.65%
Quarterly Report Q1 8-K 2021-02-28 74.97% -95.91% -95.35%
Quarterly Report Q4 8-K 2020-11-30 259.24% -47.30% -47.51%
Quarterly Report Q3 8-K 2020-08-31 -61.39% -662.96% -634.76%
Quarterly Report Q2 8-K 2020-05-31 -55.69% 347.07% -314.73%
Quarterly Report Q1 8-K 2020-02-29 -68.98% -361.49% -337.39%
Quarterly Report Q4 8-K 2019-11-30 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2019-08-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2019-05-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-02-28 0.00% 0.00% 0.00%